Outcomes of Liver Transplantation in Patients With Preexisting Coronary Artery Disease

Emily Reznicek1, Kazunari Sasaki2, Bryce Montane1

  • 1Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH.

Transplantation
|November 18, 2022
PubMed

Insights

Patients with coronary artery disease (CAD) undergoing liver transplantation face higher mortality risks, particularly from cardiovascular events. Coexisting nonalcoholic steatohepatitis (NASH) further elevates these risks, necessitating aggressive management.

Area of Science:

  • Cardiology
  • Hepatology
  • Transplantation Surgery

Background:

  • Liver transplantation technology advances enable procedures for older, higher-risk patients.
  • Cardiovascular events are a leading cause of post-transplant mortality despite cardiac testing.
  • Limited data exist on liver transplant outcomes for patients with pre-existing coronary artery disease (CAD).

Purpose of the Study:

  • To compare all-cause and cardiovascular mortality in liver transplant recipients with and without a history of coronary artery disease (CAD).

Main Methods:

  • A retrospective analysis of 693 adult liver transplant recipients between July 2013 and December 2018.
  • Comparison of mortality rates between patients with and without pre-existing CAD.
  • Follow-up analysis included assessment of cardiovascular events and survival, considering coexisting nonalcoholic steatohepatitis (NASH).

Main Results:

  • All-cause mortality was significantly higher in the CAD group (26.7%) compared to the non-CAD group (9.6%).
  • Cardiovascular events constituted a larger proportion of deaths in the CAD group (52.5%) versus the non-CAD group (36.5%).
  • Patients with combined NASH and CAD showed significantly worse survival at 6 months compared to those with either condition alone.

Conclusions:

  • Pre-existing CAD increases the risk of all-cause and cardiovascular mortality after liver transplantation.
  • The presence of nonalcoholic steatohepatitis (NASH) exacerbates mortality risk in liver transplant patients with CAD.
  • Aggressive risk factor modification is crucial for liver transplant candidates with CAD, especially those with coexisting NASH.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
36
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.0K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
23